Pathfinder

Pathfinder is Target Ovarian Cancer's ground-breaking research that provides a detailed picture of the experiences of people with ovarian cancer in the UK.

Our latest report, Pathfinder 2022: Faster, further, and fairer, tells us that progress is possible if urgent action is taken now.

It reveals that if diagnosis was faster, further support was available and access to treatment was fairer, there could be potential for more women to survive, live well with ovarian cancer and be supported from diagnosis and throughout treatment.

Pathfinder 2022

What did we find out?

Pathfinder 2022 discovered that

1/3

1/3

Of women are still waiting

over three months for a diagnosis of ovarian cancer
54%

54%

Of people diagnosed were not

asked by anyone involved in their treatment about the impact on their mental health
11%

11%

Of women waited

32 days or more to receive an ultrasound scan

Pathfinder Nations Reports

The people behind the statistics

Behind our Pathfinder report are the stories of real people whose lives have been devastated by ovarian cancer.

Take action

We need you to email your MP to ask them to work with us to raise the profile of ovarian cancer and the devastating impact it’s having on people’s lives.

It’s a quick and easy task, but the difference you’ll make is enormous!

Email your MP now

Read our previous reports

Pathfinder is Target Ovarian Cancer's ground-breaking research that provides a detailed picture of the experiences of people with ovarian cancer in the UK.

What did we find out?

1/3

Of women are still waiting

54%

Of people diagnosed were not

11%

Of women waited

Pathfinder Nations Reports

The people behind the statistics

Take action

Read our previous reports

Pathfinder 2016

Pathfinder 2012

Pathfinder 2009

Pathfinder 2016 - England

Pathfinder 2016 - N. Ireland

Pathfinder 2016 - Scotland

Pathfinder 2016 - Wales

Pathfinder 2016 - Cymru